  Along the pathogenesis of Mycobacterium Tuberculosis (MTB), hypoxia-induced
dormancy is a process involving the oxygen-depleted environment encountered
inside the lung granuloma, where bacilli enter a viable, non-replicating state
termed as latency. Affecting nearly two billion people, latent TB can linger in
the host for indefinite periods of time before resuscitating, which
significantly strains the accuracy of treatment options and patient prognosis.
Transcriptional factors thought to mediate this process have only conferred
mild growth defects, signaling that our current understanding of the MTB
genetic architecture is highly insufficient. In light of these inconsistencies,
the objective of this study was to characterize regulatory mechanisms
underlying the transition of MTB into dormancy. The project methodology
involved a three-part approach - constructing an aggregate hypoxia dataset,
inferring a gene regulatory network based on those observations, and leveraging
several downstream network analyses to make sense of it all. Results indicated
dormancy to be functionally associated with cell redox homeostasis, metal ion
cycling, and cell wall metabolism, all of which modulate essential
host-pathogen interactions. Additionally, the crosstalk between individual
regulons (Rv0821c and Rv0144; Rv1152 and Rv2359) was shown to be critical in
facilitating bacterial persistence and allowing MTB to gain control over key
micronutrients within the cell. Defense antioxidants and nutritional immunity
were also identified as future avenues to explore further. In providing some of
the first insights into the methods utilized by MTB to endure in a hypoxic
state, this research suggests a range of strategies that might aid in improved
clinical outcomes of TB treatment.
